{"organizations": [], "uuid": "9849dcc52e96ec272cc33da2199b7302340f0d55", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-recro-pharma-estimates-cash-and-ca/brief-recro-pharma-estimates-cash-and-cash-equivalents-about-64-mln-as-of-dec-31-idUSFWN1PX191", "country": "US", "domain_rank": 408, "title": "BRIEF-Recro Pharma Estimates Cash And Cash Equivalents About $64 Mln As Of Dec 31", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-07T14:39:00.000+02:00", "replies_count": 0, "uuid": "9849dcc52e96ec272cc33da2199b7302340f0d55"}, "author": "", "url": "https://www.reuters.com/article/brief-recro-pharma-estimates-cash-and-ca/brief-recro-pharma-estimates-cash-and-cash-equivalents-about-64-mln-as-of-dec-31-idUSFWN1PX191", "ord_in_thread": 0, "title": "BRIEF-Recro Pharma Estimates Cash And Cash Equivalents About $64 Mln As Of Dec 31", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-recro pharma estimates cash", "sentiment": "negative"}, {"name": "brief-recro pharma estimates cash and cash equivalents about", "sentiment": "negative"}, {"name": "recro pharma inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 7, 2018 / 12:39 PM / Updated 10 minutes ago BRIEF-Recro Pharma Estimates Cash And Cash Equivalents About $64 Mln As Of Dec 31 Reuters Staff 1 Min Read \nFeb 7 (Reuters) - Recro Pharma Inc: \n* RECRO PHARMA - ESTIMATES THAT AS OF DEC 31, 2017, CASH AND CASH EQUIVALENTS WERE APPROXIMATELY $64.0 MILLION Source text for Eikon: ( bit.ly/2nOPGN7 ) Further company coverage:", "external_links": [], "published": "2018-02-07T14:39:00.000+02:00", "crawled": "2018-02-07T14:52:43.001+02:00", "highlightTitle": ""}